1. Denmark Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Ambu A/S

Ambu A/S

AMBU-B.CO
Ambu A/SDK flagNASDAQ Copenhagen
66.75
DKK
+0.10
- -
17.74BMarket Cap
Ambu A/S
AMBU-B.CO
(NASDAQ Copenhagen)

Recent

price

66.75

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
3.72
4
4.21
4.48
5.91
6.68
7.86
8.79
9.94
10.72
11.54
14.47
15.94
17.5
18.33
20.24
22.36
Revenue per Share
0.24
0.36
0.3
0.47
0.2
0.64
0.63
1.05
1.27
1.39
1.3
0.98
0.98
0.37
0.64
0.88
1.35
Basic EPS, GAAP
0.24
0.13
0.25
0.55
0.52
0.73
0.87
1.31
1.95
1.31
1.11
-0.55
-1.02
-1.8
0.74
1.97
1.41
Free Cash Flow per Basic Share
0.08
0.08
0.12
0.1
0.15
0.06
0.19
0.19
0.32
0.38
0.41
0.39
0.29
0.3
- -
- -
0.38
Dividend per Share
2.01
2.33
2.35
2.62
2.73
3.2
3.47
3.17
4.5
6.96
7.9
9.03
14.98
15.28
19.89
20.46
22.02
Book Value per Share
1.1
1.46
1.53
1.87
-1.16
-0.62
-0.21
-1.05
0.27
-3.12
-2.48
-2.28
2.81
2.53
6.84
8.88
10.02
Tangible Book Value per Share
236
235
234
233
234
237
240
237
237
243
244
247
252
254
260
266
267
Basic Weighted Avg Shares
877
940
983
1,045
1,383
1,584
1,889
2,084
2,355
2,606
2,820
3,567
4,013
4,444
4,775
5,391
5,958
Sales/Revenue/Turnover
12.58
12.59
14.68
14.45
11.42
12.5
12.76
17.08
19.53
21.6
17.02
12
8.47
2.75
6.32
11.96
13.16
Operating Margin (%)
56
61
56
53
74
88
96
102
105
115
109
181
216
351
348
696
704
Depreciation Expense
56
84
69
110
48
151
152
250
301
337
317
241
247
93
168
235
359
Net Income, GAAP
24.32
27.58
29.42
23.61
31.43
27.4
29.3
23.31
23.41
27.53
23.24
25.16
19.81
14.68
20
21.67
15.33
Effective Tax Rate (%)
6.36
8.94
7.04
10.53
3.47
9.53
8.05
12
12.78
12.93
11.24
6.76
6.15
2.09
3.52
4.36
6.03
Profit Margin (%)
152
206
231
297
298
351
400
381
-284
511
154
197
628
1,143
1,066
1,578
1,929
Working Capital
57
44
30
18
753
702
700
925
83
1,304
1,151
1,401
760
1,766
512
483
459
LT Debt
480
562
580
665
651
854
1,036
990
1,279
1,882
2,182
2,372
3,952
4,261
5,393
5,594
5,905
Total Equity
14.09
13.17
14.39
15.39
9.73
9.07
9.46
13.94
17.13
15.29
11.06
8.91
6.37
1.91
4.01
8.32
10.32
Return on Invested Capital (%)
10.7
14.1
11.72
16.47
5.83
11.92
10.8
16.28
18.15
14.81
10.92
7.75
6.48
2.33
3.77
4.35
6.28
Return on Capital (%)
12.29
16.49
12.62
18.97
7.69
21.62
19.11
31.55
33.1
24.43
17.49
11.59
8.24
2.43
3.71
4.42
6.28
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'25
ST Debt
75
76
75
LT Borrowings
- -
- -
- -
LT Finance Leases
489
478
459
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
266
266
266
Market Capitalization
27,781
31,452
26,490

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'25
Total Current Assets
2,808
2,891
2,943
Cash, Cash Equivalents & STI
588
640
751
Accounts Receivable, Net
826
877
852
Inventories
1,228
1,214
1,193
Total Current Liabilities
1,078
1,003
1,014
Payables & Accruals
- -
- -
- -
ST Debt
75
76
75
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.26%
22.69%
3.73%
Free Cash Flow
12.33%
9.98%
172.92%
Net Income, GAAP
12.83%
7.34%
39.88%
Sales/Revenue/Turnover
13.15%
14.02%
12.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,254
1,367
1,383
1,387
5,391
2025
1,573
1,554
1,507
1,558
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.35
0.54
0.5
-0.51
0.88
2025
0.46
0.71
0.46
0.44
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
0.08
0.08
- -
0.34
- -
Similar Companies
Scandinavian Medical Solutions A/S (SMSMED.CO)
Acutus Medical, Inc. (AFIB)
Nemaura Medical Inc. (NMRD)
Lutronic Corp (085370.KS)
Duearity AB (publ) (DEAR.ST)
Enovis Corporation (ENOV)
Business
Ambu A/S (Ticker: AMBU-B.CO) develops, manufactures, and markets single-use flexible endoscopic devices and related visualization systems for medical diagnostics and treatment procedures. The company offers a comprehensive portfolio of products including flexible endoscopes such as the aScope line of bronchoscopes, duodenoscopes, cystoscopes, and ureteroscopes; disposable sheaths and cleaning brushes; and advanced imaging solutions like the aView and aBox systems for video processing and display. Ambu also provides rigid endoscopy products, patient monitoring devices, and resuscitators, serving healthcare providers in hospitals, clinics, and ambulatory settings worldwide. Founded in 1937 and headquartered in Ballerup, Denmark, Ambu operates globally with manufacturing facilities in Europe, North America, and Asia, targeting key markets in endoscopy, anesthesia, and cardiology segments. Its core customer base includes physicians, nurses, and medical facilities focused on minimally invasive procedures, with a strong emphasis on infection prevention through single-use devices. The company maintains subsidiaries in major regions, including Ambu Inc. in the United States, supporting its international expansion. In the last 1-2 years, Ambu has launched several new products, including the aScope™ 5 Slim Broncho and advancements in its aScope™ Gastro platform for gastrointestinal endoscopy, enhancing procedural efficiency and safety. The company completed strategic acquisitions such as the 2024 purchase of a key visualization technology firm to bolster its digital endoscopy offerings and formed partnerships with leading hospital networks for pilot programs in single-use endoscopy adoption. Additionally, Ambu announced expansions in its U.S. manufacturing capacity in 2025 to meet growing demand in North American markets amid regulatory shifts favoring disposable devices.